Zorn Holger, Barat Baviera José Manuel, Bolognesi Claudia, Catania Francesco, Gadermaier Gabriele, Greiner Ralf, Mayo Baltasar, Mortensen Alicja, Roos Yrjö Henrik, Solano Marize L M, Sramkova Monika, Van Loveren Henk, Vernis Laurence, Cavanna Daniele, Liu Yi, di Piazza Giulio
EFSA J. 2024 Jul 24;22(7):e8940. doi: 10.2903/j.efsa.2024.8940. eCollection 2024 Jul.
The food enzyme oryzin (EC 3.4.21.63) is produced with the non-genetically modified strain AE-P by Amano Enzyme Inc. A safety evaluation of this food enzyme was made previously, in which EFSA concluded that this food enzyme did not give rise to safety concerns when used in nine food manufacturing processes. Subsequently, the applicant has requested to extend its use to one additional process, to withdraw two food processes and to revise the use levels. In this assessment, EFSA updated the safety evaluation of this food enzyme when used in a total of eight food manufacturing processes. The dietary exposure to the food enzyme-total organic solids (TOS) was calculated to be up to 0.354 mg TOS/kg body weight (bw) per day in European populations. When combined with the no observed adverse effect level reported in the previous opinion (1862 mg TOS/kg bw per day, the highest dose tested), the Panel derived a margin of exposure of at least 5260. Based on the data provided for the previous evaluation and the revised margin of exposure in the present evaluation, the Panel concluded that this food enzyme does not give rise to safety concerns under the revised intended conditions of use.
食品酶类胰蛋白酶(EC 3.4.21.63)由天野酶制剂公司使用非转基因菌株AE-P生产。此前已对该食品酶进行了安全性评估,欧洲食品安全局(EFSA)得出结论,该食品酶在九种食品制造工艺中使用时不会引发安全问题。随后,申请人请求将其使用范围扩展至一种额外的工艺,撤回两种食品工艺并修订使用水平。在本次评估中,EFSA更新了该食品酶在总共八种食品制造工艺中使用时的安全性评估。据计算,欧洲人群通过膳食摄入该食品酶的总有机固体(TOS)量最高可达每天0.354毫克TOS/千克体重(bw)。结合先前意见中报告的未观察到不良反应水平(每天1862毫克TOS/千克体重,为测试的最高剂量),专家小组得出的暴露边际至少为5260。根据先前评估提供的数据以及本次评估中修订后的暴露边际,专家小组得出结论,在修订后的预期使用条件下,该食品酶不会引发安全问题。